Bronchogen

Bronchogen

Bronchogen

ʻO Bronchogen kahi peptide pōkole bioactive i haku ʻia me ʻehā amino acids; he lālā o ka ʻohana peptides regulatory epigenetic.

Pane wikiwiki

Source premium Bronchogen bioactive peptide featuring excellent bronchial soothing and respiratory conditioning effects. Ideal for pulmonary health formula development, with stable quality for global bulk supply and scientific lab research.

SKU: 198820 Māhele:
Kaʻana like i kāu aloha

ʻO Bronchogen kahi peptide pōkole bioactive i haku ʻia me ʻehā amino acids; he lālā o ka ʻohana peptides regulatory epigenetic. Hoʻomaka mua ʻia e kahi hui noiʻi ma ka Institute of Bioregulation and Gerontology ma St. Petersburg, Lukia, hoʻohana nui ia i nā hopena pale a hoʻoponopono i ka ʻiʻo māmā.

Hoʻoponopono i ka hōʻike gene a ma hope hoʻohui pūmua ʻo ia nā ʻano hana koʻikoʻi e hoʻopili ʻia ai kēia mau hopena.

Kaʻina

Ala-Glu-Asp-Leu

Helu CAS

/

ʻĀpana Molekala

C18H30N4O9

Kaumaha Molekala

446.45

Noi'i o Bronchogen Peptide

1.Chromatin-Hana ʻia ʻo Bronchogen i ka hoʻihoʻi ʻana i ka hana Pulmonary

Hōʻike nā haʻawina e pili pono ana ʻo Bronchogen i nā histones (H1, H2b, H3, ʻO H4 nā laʻana mua) a me DNA; epigenetic ʻO ka hoʻoponopono ʻana i nā genes pili i ka hana o ka māmā ka mea nui.

Ua hōʻike nā ʻano hoʻokolohua i nā hopena hoʻihoʻi – pneumonia maʻi bacteria, nā ʻano like ʻole o ka maʻi maʻi fibrosis puʻupuʻu, a me nā ʻano like ʻole o ka ʻeha o ka maʻi ʻawaʻawa.

ʻO ka hoʻomaikaʻi ʻana i ka morphology a me ka hana o nā cell epithelial bronchial kahi hopena kūlike o kēia mālama ʻana.

ʻO ke ʻano o ka hana ponoʻī he multifaceted, ʻO ka hoʻoponopono epigenetic ke kia waena, ka hana cellular a me ka homeostasis kiko ma muli o ka hopena pololei.

2.Hoʻoponopono Gene Expression: Nā hopena anti-inflammatory a me Anti-fibrotic

ʻO ka hoʻololi ʻana i ka hana transcriptional ka hana koʻikoʻi o Bronchogen.

Loaʻa ka hana preclinical a ke ʻike mau nei i nā ʻano genes i hoʻopili ʻia e ia.

Hoʻoponopono i nā mea transcription (a me nā genes marker) pili me ka alveolar epithelial differentiation ua palapala maikaʻi (NKX2-1, ʻO nā lālā o ka ʻohana FOX nā kumu hoʻohālike).

Hoʻopili pū ʻia nā protein huna e like me SCGB1A1/3A2.

Mālama ʻia ka paʻa o ka alveolus a me ka hana surfactant e kēia mau genes.

Nā genes pili i ka inflammatory (CD79A, NOS-3 inā mālama ka hoʻomanaʻo) ua hooponopono like – ʻO ka ʻeha nui a i ʻole ka mālama ʻole ʻia kahi hopena pathological nui o ka maʻi māmā, a ʻo Bronchogen ka mea e hoʻemi iki ai.

Ua kākoʻo maikaʻi ʻia nā hopena anti-inflammatory a me anti-fibrotic o Bronchogen i nā ʻano hoʻohālike.

3.ʻO ka hoʻonui a me ka hoʻokaʻawale

Hōʻike nā haʻawina i ka hoʻopili ʻana o Bronchogen i nā genes e pili ana i ka pōʻai cell a me ka apoptosis.

Kūkākūkā, hoʻololi ʻo ia i ka hōʻike ʻana o kahi moʻo hōʻailona hoʻonui cell, MKI67 (Ki67), a me nā ʻano gen anti-apoptotic like ʻole MCL1; ka gene suppressor tumor TP53 (p53) ʻo ia kekahi o nā laʻana i aʻo nui ʻia.

ʻO kēia hana hoʻoponopono e hoʻoikaika i ka hoʻoponopono ʻana i ke kino ma hope o ka ʻeha, me ke kaohi ʻana i ka hoʻonui ʻia ʻana o nā cell abnormal i makemake ʻia he wahi hope⁵.

I kēia manawa, kūʻai nui ʻia ʻo Bronchogen ma ke ʻano he meaʻai meaʻai a i ʻole peptide bioregulator – he 'peptide complex no ka bronchopulmonary system’ inā makemake ʻoe.

ʻO ka lāʻau hoʻohui no ka bronchitis mau, ʻO ka maʻi obstructive pulmonary (COPD) a me ka bronchial hānō ʻo ia ka hoʻohana maʻamau; hoihoi hou ana (ma ka hapa iki) ka hana mucosal bronchial, ka hoʻomaikaʻi ʻana i ka hana pulmonary, ʻO ka hoʻonui ʻana i ka hana surfactant a ma hope o ka hoʻohuli ʻana i ka emi ʻana o nā makahiki like ʻole i ka hana o ka māmā ka mea i manaʻo ʻia no nā hopena..

Hoʻohui ʻia ka Bronchogen me nā peptides ʻē aʻe, ʻO ka hoʻihoʻi ʻana i ka hana o ka māmā ma hope o COVID-19 kahi wahi kikoʻī o ka hoihoi; ʻO ka hoʻoponopono ʻana o ka immune a me ke ʻano alveolar ʻelua i manaʻo ʻia e hoʻoponopono ʻia e ia.

Ke kali ʻia nei ka hōʻoia ʻana o ke kino o nā hoʻohana āpau a me ka wā e hiki mai ana.

COA

HPLC

MS

(1) Khavinson, V. K.; Popovich, I. ʻO G. e.; Nā loulou, N. S.; Mironova, E. S.; Ilina, A. R. Hoʻoponopono Peptide o Gene Expression: He Manao Manao. Nā Molekula 2021, 26 (22). DOI: 10.3390/nā mole26227053.

(2) B. F. ʻO Vanyushin, V. K. K. Pōkole Biologically Active Peptides e like me Epigenetic Modulators o Gene Activity. In Epigenetics – He ala ʻokoʻa o ka nānā ʻana i nā Genetics Walter Doerfler, P. B. ʻO Ed.; 2016; pp 66-90.

(3) Morozova, E. A.; Paʻakikī au, N. S.; Khavinson, V. K.; Soloviev, A. Y.; Kasyanenko, N. A. ʻO ka pilina in vitro o ka peptide AEDL me DNA. Nūpepa o Structural Chemistry 2017, 58 (2), 420-424. DOI: 10.1134/S0022476617020299.

(4) Ma hope aku, N. A.; Lebedeva, E. S.; Dvorakovskaya, I. V.; Surkova, E. A.; Platonova, I. S.; Ko Tito, O. N. Hoʻololi i ka hopena o ka Peptide Therapy ma ka Morphofunctional State of Bronchial Epithelium i nā ʻiole me ka Obstructive Lung Pathology.. Bulletin of Experimental Biology and Medicine 2015, 159 (5), 685-688. DOI: 10.1007/s10517-015-3047-x.

(5) Khavinson, V.; Nā loulou, N.; He mea hou, E.; Bolshakova, A.; Gainullina, A.; Kahuna, S.; Morozova, E.; ʻO Tarnovskaya, S.; Hāʻule ʻo Vinski, ʻO D. S.; Nina Kasyanenko, V. B. ʻO ka hopena neuroprotective o EDR Peptide i ka Kiole Model o ka maʻi o Huntington. Nūpepa o ka Neurology a me Neuroscience 2017, 08 (01). DOI: 10.21767/2171-6625.1000166.

(6) Khavinson, V.; Nā loulou, N.; Dyatlova, A.; Kuznik, B.; ʻO Umnov, R. Nā peptide: Nā Manaʻo no ka hoʻohana ʻana i ka mālama ʻana o COVID-19. Nā Molekula 2020, 25 (19). DOI: 10.3390/nā molekala25194389.

Kaʻina:

Ala-Glu-Asp-Leu

CAS:

/

M.W:

446.45 g/mol

Home Huli Whatsapp Nā lawelawe Huahana